Decreasing incidence of subarachnoid hemorrhage.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 27 04 2018
revised: 01 08 2018
accepted: 03 08 2018
pubmed: 14 10 2018
medline: 10 4 2019
entrez: 14 10 2018
Statut: ppublish

Résumé

To determine the incidence and trends in subarachnoid hemorrhage in Ireland using data from a national database. We performed a retrospective nationwide query of the Irish Hospital In-patient Enquiry System (HIPE). This is a national database of all in-patient activity in acute public hospitals in Ireland. Each HIPE entry records one episode of in-patient care. The study period ranged from 1997 to 2015. Population data was obtained from the Irish Central Statistics Office, and the annual prevalence of smoking from the Irish National Tobacco Control Office. We were therefore able to calculate both crude annual acute subarachnoid hemorrhage (SAH) incidence rates, as well as population-standardized rates, and compared them with trends in the annual smoking rates. The mean number of SAH cases per year is 549, with 465 cases in 1997 and 517 in 2015 (range: 465-624). The absolute incidence of SAH, therefore, remained relatively stable. Due to population increases over time, the population-adjusted rate of SAH therefore decreased, from 126.9/million people/year in 1997 to 111.5/million people/year in 2015. Nationally, there was a decrease in smoking prevalence, from 31% in 1998 to 19.2% in 2015. There was a statistically significant correlation between decreasing smoking rates and decreasing population-adjusted incidence of SAH (P=<0.0001). Our data suggests that the incidence of non-traumatic subarachnoid hemorrhage in our population appears to be decreasing, a decrease which is correlated with decreasing smoking rates. This provides important data both in terms of the epidemiology of SAH, as well as the possible role of public-health interventions in tackling both smoking and declining rates of SAH.

Identifiants

pubmed: 30314993
pii: neurintsurg-2018-014038
doi: 10.1136/neurintsurg-2018-014038
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-322

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Patrick Nicholson (P)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Alan O'Hare (A)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Sarah Power (S)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Seamus Looby (S)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Mohsen Javadpour (M)

Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland.

John Thornton (J)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.
Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland.

Paul Brennan (P)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH